155 related articles for article (PubMed ID: 25932135)
1. Prognostic value of ALDH1 expression in lung cancer: a meta-analysis.
Huo W; Du M; Pan X; Zhu X; Li Z
Int J Clin Exp Med; 2015; 8(2):2045-51. PubMed ID: 25932135
[TBL] [Abstract][Full Text] [Related]
2. ALDH1 Expression and the Prognosis of Lung Cancer: A Systematic Review and Meta-Analysis.
Wei D; Peng JJ; Gao H; Zhang T; Tan Y; Hu YH
Heart Lung Circ; 2015 Aug; 24(8):780-8. PubMed ID: 25921687
[TBL] [Abstract][Full Text] [Related]
3. The prognostic role of the cancer stem cell marker aldehyde dehydrogenase 1 in head and neck squamous cell carcinomas: a meta-analysis.
Zhou C; Sun B
Oral Oncol; 2014 Dec; 50(12):1144-8. PubMed ID: 25264224
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological characteristics and prognostic value of the cancer stem cell marker ALDH1 in ovarian cancer: a meta-analysis.
Zhao W; Zang C; Zhang T; Li J; Liu R; Feng F; Lv Q; Zheng L; Tian J; Sun C
Onco Targets Ther; 2018; 11():1821-1831. PubMed ID: 29662319
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Value of Cancer Stem Cell Marker ALDH1 Expression in Colorectal Cancer: A Systematic Review and Meta-Analysis.
Chen J; Xia Q; Jiang B; Chang W; Yuan W; Ma Z; Liu Z; Shu X
PLoS One; 2015; 10(12):e0145164. PubMed ID: 26682730
[TBL] [Abstract][Full Text] [Related]
6. The clinical and prognostic impact of aldehyde dehydrogenase 1 in non-small cell lung cancer: a meta-analysis.
Xue J; Zhao Y; Zou Q; Liang F; Lin F
Transl Cancer Res; 2020 Mar; 9(3):1914-1925. PubMed ID: 35117538
[TBL] [Abstract][Full Text] [Related]
7. The Clinical Significance and Prognostic Value of ALDH1 Expression in Non-small Cell Lung Cancer: A Systematic Review and Meta-analysis.
Li D; Cao Y; Luo CW; Zhang LP; Zou YB
Recent Pat Anticancer Drug Discov; 2023 Oct; ():. PubMed ID: 37818578
[TBL] [Abstract][Full Text] [Related]
8. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
[TBL] [Abstract][Full Text] [Related]
9. Metastasis-associated in colon cancer-1 and aldehyde dehydrogenase 1 are metastatic and prognostic biomarker for non-small cell lung cancer.
Zhou L; Yu L; Zhu B; Wu S; Song W; Gong X; Wang D
BMC Cancer; 2016 Nov; 16(1):876. PubMed ID: 27832750
[TBL] [Abstract][Full Text] [Related]
10. Differences in expression of the cancer stem cell marker aldehyde dehydrogenase 1 among estrogen receptor-positive/human epidermal growth factor receptor type 2-negative breast cancer cases with early, late, and no recurrence.
Miyoshi Y; Shien T; Ogiya A; Ishida N; Yamazaki K; Horii R; Horimoto Y; Masuda N; Yasojima H; Inao T; Osako T; Takahashi M; Tomioka N; Endo Y; Hosoda M; Doihara H; Miyoshi S; Yamashita H;
Breast Cancer Res; 2016 Jul; 18(1):73. PubMed ID: 27368476
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological and Prognostic Significance of Cancer Stem Cell Markers in Ovarian Cancer Patients: Evidence from 52 Studies.
Tao Y; Li H; Huang R; Mo D; Zeng T; Fang M; Li M
Cell Physiol Biochem; 2018; 46(4):1716-1726. PubMed ID: 29730663
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological significance of cancer stem-like cell markers in high-grade neuroendocrine carcinoma of the lung.
Morise M; Hishida T; Takahashi A; Yoshida J; Ohe Y; Nagai K; Ishii G
J Cancer Res Clin Oncol; 2015 Dec; 141(12):2121-30. PubMed ID: 25963795
[TBL] [Abstract][Full Text] [Related]
13. The prognostic role of the cancer stem cell marker CD44 in ovarian cancer: a meta-analysis.
Lin J; Ding D
Cancer Cell Int; 2017; 17():8. PubMed ID: 28070170
[TBL] [Abstract][Full Text] [Related]
14. ALDH1 as a prognostic marker for lymph node metastasis in OSCC.
Götz C; Bissinger O; Nobis C; Wolff KD; Drecoll E; Kolk A
Biomed Rep; 2018 Oct; 9(4):284-290. PubMed ID: 30233780
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of aldehyde dehydrogenase 1 and transcription factors in both primary breast cancer and axillary lymph node metastases as a prognostic factor.
Ito M; Shien T; Omori M; Mizoo T; Iwamoto T; Nogami T; Motoki T; Taira N; Doihara H; Miyoshi S
Breast Cancer; 2016 May; 23(3):437-44. PubMed ID: 25599843
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Impact and Clinicopathological Correlation of CD133 and ALDH1 Expression in Invasive Breast Cancer.
Kim SJ; Kim YS; Jang ED; Seo KJ; Kim JS
J Breast Cancer; 2015 Dec; 18(4):347-55. PubMed ID: 26770241
[TBL] [Abstract][Full Text] [Related]
17. The prognostic impact of cancer stem-like cell biomarker aldehyde dehydrogenase-1 (ALDH1) in ovarian cancer: A meta-analysis.
Ruscito I; Darb-Esfahani S; Kulbe H; Bellati F; Zizzari IG; Rahimi Koshkaki H; Napoletano C; Caserta D; Rughetti A; Kessler M; Sehouli J; Nuti M; Braicu EI
Gynecol Oncol; 2018 Jul; 150(1):151-157. PubMed ID: 29753392
[TBL] [Abstract][Full Text] [Related]
18. Aldehyde dehydrogenase 1 expression is a predictor of poor prognosis in node-positive breast cancers: a long-term follow-up study.
Yoshioka T; Umekita Y; Ohi Y; Souda M; Sagara Y; Sagara Y; Sagara Y; Rai Y; Tanimoto A
Histopathology; 2011 Mar; 58(4):608-16. PubMed ID: 21371077
[TBL] [Abstract][Full Text] [Related]
19. Aldehyde dehydrogenase 1 expression has prognostic significance in patients with glioma.
Wang J; Yang CL; Zou LL
Mol Clin Oncol; 2017 Nov; 7(5):885-890. PubMed ID: 29075491
[TBL] [Abstract][Full Text] [Related]
20. Systematic review of CYFRA 21-1 as a prognostic indicator and its predictive correlation with clinicopathological features in Non-small Cell Lung Cancer: A meta-analysis.
Yu Z; Zhang G; Yang M; Zhang S; Zhao B; Shen G; Chai Y
Oncotarget; 2017 Jan; 8(3):4043-4050. PubMed ID: 28008142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]